project id: TCGA-COAD; case submitter id: TCGA-AD-6901; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 78; days to birth: -28579; days to death: 682; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1933; age at diagnosis: 28579; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 31.0; icd 10 code: C18.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: No; tissue or organ of origin: Cecum; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 38.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.3; longest dimension: 0.7; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-AD-6901-01A-11; percent lymphocyte infiltration: 5.0; percent necrosis: 2.0; percent normal cells: 0.0; percent stromal cells: 45.0; percent tumor cells: 55.0; percent tumor nuclei: 60.0;